Complete report $9,800. DataPack (test volumes, sales forecasts, supplier shares) $6,400.
VPGMarketResearch.com's new report is a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the US cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.
Business Opportunities and Strategic Recommendations
- Specific new product development opportunities with potentially
significant market appeal during the next five years.
- Design criteria for new products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
Cancer Diagnostic TestsOver 200 current and emerging assays including:
ACTH, AFP, Beta-2 Microglobulin, CA 15-3/27.29, CA 19-9, CA 125, Calcitonin, Cathepsin, CEA,
Chromogranin, Colon-Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG,
Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific Enolase, Nucleolar,
Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone,
Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein,
Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin,
Tissue Polypeptide Antigen, and others.
Market Segmentation Analysis
- Sales and market shares of major suppliers,
by individual cancer diagnostic test.
- Five-year test volume and sales forecasts
for major cancer diagnostic tests by market segment, including:
- Commercial/Private Laboratories
- Physician Offices/Group Practices
- Cancer Clinics
- Comprehensive market segmentation analysis, including review
of the market dynamics, structure, size, growth and major suppliers.
- Cancer statistics, etiology and recent developments.
Current and Emerging Products
- Review of over 200 current and emerging cancer diagnostic tests,
- Biochemical Markers
- Growth Factors
- Colony Stimulating Factors
- Immunohistochemical Stains, and others.
- Analysis of major immunoassay analyzers used for
cancer diagnostic testing, including their operating characteristics,
features and selling prices.
- Assessment of monoclonal antibodies, immunoassays, DNA
probes, biochips/microarrays, chromosome analysis, IT,
artificial intelligence, flow cytometry, biosensors, and other technologies
and their potential applications for cancer diagnostic testing.
- Review of competing/complementing technologies, including
CT, MRI, NMR, PET and photonics spectroscopy.
- Extensive listings of over 500 companies, universities
and research centers developing new cancer diagnostic tests
and detection technologies.
- Strategic assessments ofmajor suppliers
and start-up firms developing innovative
technologies and products, including their sales,
product portfolios, marketing tactics, collaborative
arrangements, and new products in R&D.
Contains 620 pages and 103 tables
SIMILAR MARKET STUDIES
VPGMarketResearch.com's new report is a strategic analysis of major business opportunities emerging in the Italian clinical chemistry and immunodiagnostic markets during the next five years. The report explores future trends in the German market; provides estimates of the specimen, test and sales volumes, as well as major suppliers’ sales and market ...
December 2016 | $0 | View Details >>
This new report from VPGMarketResearch provides analysis of GGT testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing; - Hospitals - Commercial/Private Laboratories POC/Decentralized Testing - Physician Offices/Group Practices - ...
March 2017 | $0 | View Details >>
This DataPack contains tables from VPGMarketResearch.com new report, 2016 France Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies. For pricing information on DataPack sections or individual tables, please contact Customer Service.
February 2016 | $0 | View Details >>
2017 Thailand Automated Microbiology Market: Molecular Diagnostics, Identification, Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics-- Specimen, Test, and Sales Forecasts, Competitive Strategies, Opportunities
This new report from VPGMarketResearch.com examines current and emerging assays; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay and application; profiles leading players and potential market entrants; and suggests alternative ...
January 2017 | $0 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research